The transcription factor SPDEF, which has been reported to suppress metastasis via inhibition of EMT in prostate cancer and is known to have low expression in NEPC compared with CRPC, also demonstrated lower mRNA expression in our AIPC cohort compared with the non-AIPC cohort [12]. Here, SPDEF is linked to prostate carcinoma.